Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5971-5980 of 10871

Edit search filters
  1. A Study of Pre-Surgery Inspiratory Muscle Training for Patients who will have Surgery on Their Esophagus

    Rochester, MN

  2. MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

  3. Stopping Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients

    Rochester, MN

  4. Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer who Completed Pre-operative Therapy

    Rochester, MN

  5. Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH

    Rochester, MN

  6. Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

    Rochester, MN

  7. Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

    Rochester, MN

  8. Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure

    Rochester, MN

  9. Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study)

    Scottsdale/Phoenix, AZ

  10. GS-4997 in Adults With Pulmonary Arterial Hypertension

    Rochester, MN

.

Mayo Clinic Footer